Loading people...
Aman Johar is a Partner at Capital One Ventures and a Strategic Technology Advisor at the Innovation Institute for Fan Experience, based in the United States. He previously co-founded Applied Protein, a technology company that was acquired by Pivot Pharma, and currently serves as a board member for 3D battery printing startup KeraCel. Johar holds a Bachelor of Technology in Electrical Engineering from the Indian Institute of Technology Varanasi, a Master of Science from the University of Illinois at Chicago, and a Master of Business Administration from Carnegie Mellon University. During his time at Carnegie Mellon's Tepper School of Business, he was recognized as a Swartz Fellow for his work in entrepreneurship and venture strategy. His current investment and advisory focus centers on scaling high-growth technology startups across the enterprise software, cybersecurity, artificial intelligence, and financial services sectors.
Aman Johar is a distinguished Principal at Proteum Capital, a prominent venture capital firm known for its strategic investments in groundbreaking companies. In his role, Aman is instrumental in leading investment initiatives, conducting thorough due diligence, and providing invaluable strategic guidance to portfolio companies. His expertise lies in identifying early to growth-stage companies with strong potential for market disruption and sustainable growth.
At Proteum Capital, Aman's investment focus is broad yet targeted, primarily concentrating on sectors driven by technological innovation. This includes areas such as enterprise software (SaaS), artificial intelligence, fintech, healthcare technology, and consumer internet. He is particularly drawn to businesses that leverage proprietary technology to solve complex problems, create new markets, or significantly improve existing industries. Aman works closely with founders and management teams, offering not just capital but also operational insights, strategic planning, and network access to accelerate their development and market penetration.
Prior to joining Proteum Capital, Aman built a robust career foundation rooted in finance and strategic advisory. His background includes experience in investment banking and management consulting, where he advised numerous companies on mergers and acquisitions, capital raises, and operational efficiencies. This diverse experience equipped him with a comprehensive understanding of business fundamentals, market dynamics, and the critical factors that drive successful ventures. His analytical rigor and strategic foresight are key assets in his current role, enabling him to spot promising opportunities and navigate complex investment landscapes.
While specific notable investments are proprietary to Proteum Capital's portfolio, Aman has been a key contributor to several successful exits and significant growth stories within the firm's diverse holdings. His contributions reflect a keen eye for identifying companies with strong leadership, scalable business models, and defensible market positions. Aman is passionate about fostering innovation and empowering entrepreneurs to realize their visions, making him a trusted partner for founders seeking capital and strategic support. His commitment to long-term value creation underscores his approach to every investment, ensuring that Proteum Capital's portfolio companies are well-positioned for enduring success.
Aman Johar is a Principal at Proteum Capital, a venture capital firm. He is responsible for leading investment initiatives, conducting due diligence, and providing strategic support to high-growth portfolio companies.
Aman Johar primarily invests in early to growth-stage companies across various technology sectors. His focus areas include enterprise software (SaaS), artificial intelligence, fintech, healthcare technology, and consumer internet, particularly businesses with disruptive technologies and strong market potential.
Aman Johar works as a Principal at Proteum Capital, a prominent venture capital firm known for its strategic investments in innovative and high-growth companies.
